Clinical Characteristics of SGLT2 Inhibitor User in Type 2 Diabetes with Atherosclerotic Cardiovascular Disease or Heart Failure in a Real-World Setting

Topics: 

Citation
Jeong SJ et al. Diabetes Jun 2019;68(Supplement 1):2346-PUB.